We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Toshiba Medical Systems to Acquire Vital Images

By HospiMedica International staff writers
Posted on 09 May 2011
Toshiba Medical Systems Corporation (TMSC; Otawara Tochigi Japan) and Vital Images (Minneapolis, MN, USA) have announced a definitive agreement pursuant to which a subsidiary of TMSC will acquire all of the outstanding shares of common stock of Vital Images for approximately US$273 million in the aggregate, through a cash tender offer followed by a merger.

Vital Images is a leading provider of advanced visualization and analysis software for physicians and healthcare specialists, providing platforms that offer users productivity and communication tools to improve patient care that can be accessed throughout the enterprise via the internet. More...
The merger will aid TMSC to expand its presence in medical diagnostic imaging systems and comprehensive medical solutions, such as computerized tomography (CT), X-ray and vascular angiography, ultrasound, nuclear medicine, and magnetic resonance imaging (MRI) systems, as well as information systems for medical institutions.

"We have enormous respect for Vital's products, pipeline and people, and look forward to working with their highly skilled team to enhance clinical value for patients throughout the world," said Satoshi Tsunakawa, CEO of TMSC. "This transaction will allow TMSC to significantly strengthen its imaging solutions business by integrating our technologies to meet the global demand for advanced visualization and imaging informatics provided to healthcare professionals and through healthcare IT providers."

"TMSC has been our largest customer for a decade, as well as a strategic development partner," said Michael Carrel, CEO of Vital Images. "We will combine forces to enhance the multimodality platform we have been marketing to hospitals in the US and overseas. This transaction means we can now accelerate our global presence with the strength and backing of TMSC."

The closing of the tender offer is conditioned on, among other things, the transfer of at least a majority of the outstanding shares of Vital Image's common stock on a fully diluted basis, required regulatory approvals, and other customary closing conditions. It is expected that the transaction will close in the second or third quarter of 2011.

Related Links:
Toshiba Medical Systems Corporation
Vital Images



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Imaging Table
Stille imagiQ2
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.